Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of <i>Candida glabrata</i>

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Antifungals</td><td class="align_center">Number of strains (%)</td><td class="align_center">Clinical specimen (number of strains)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">AMB and FLC</td><td class="align_center">5 (5.5)</td><td class="align_center">Bronchoalveolar lavage (1), pleural fluid (1), blood (2), vaginal secretion (1)</td></tr><tr><td class="align_left">AMB, FLC, and MCF</td><td class="align_center">1 (1.1)</td><td class="align_center">Feces (1)</td></tr><tr><td class="align_left">FLC and ITC</td><td class="align_center">2 (2.2)</td><td class="align_center">Sputum (1), urine (1)</td></tr><tr><td class="align_left">FLC and MCF</td><td class="align_center">2 (2.2)</td><td class="align_center">Blood (1), vaginal secretion (1)</td></tr><tr><td class="align_left">FLC, ITC, and MCF</td><td class="align_center">1 (1.1)</td><td class="align_center">Vaginal secretion (1)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>AMB: amphotericin B; FLC: fluconazole; ITC: itraconazole; MCF: micafungin.<br/></td></tr></table>

Resistance to at least two antifungal drugs in Brazilian clinical strains of <i>Candida glabrata.</i>

Mediators of Inflammation

tab2

Table 2

Table 2: Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of <i>Candida glabrata</i> 

Table 2 | Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata 